GMPs for Medical Marijuana Production Operations

Why Should You Attend:

The medical marijuana industry is in its infancy in the United States. A large number of individual states have legalized medical marijuana to varying levels of control and regulation. Medical marijuana is illegal on a US Federal level but all predictions are that this situation will change…exactly when is not clear….but it is difficult if not impossible to “put the genie back into the bottle.”

Since medical marijuana is not a legally recognized and regulated medicinal product in the US, You can only review GMPs as they relate to the wide range of international and US individual state cannabis regulations along with existing non-cannabis GMPs to determine how to best operate our cannabis operations.

It is critical as cannabis production takes its place in the mainstream of US medicinal production, that all companies currently operating under individual state auspices understand and align their operations with existing GMPs to be in compliance when cannabis is federally recognized.

This webinar will provide the foundation to the understanding of GMPs in pharmaceuticals in terms of cannabis growing and production.

Areas Covered in the Webinar:

• Overview of GMPs - Why are GMPs important?
• Regulatory history
• Forms of medical marijuana
• General Requirements – Acquisition of cannabis
• Operational Plans and Procedures
• Personnel
• Documentation and training
• Facilities – Grower/Processor
• Plants versus Seeds
• Visitor Access
• Security and surveillance
• Growing and processing requirements
• Inventory
• Storage
• Equipment Operation & Maintenance
• Sanitation and safety
• Packaging and labeling
• Transportation and tracking
• Disposal of medical marijuana waste
• Complaints & recall handling
• Pesticides and pest handling

Who Will Benefit:

All levels and functions within the Cannabis production operation would benefit from this basic GMP training.

• Associates
• Supervisors
• Associate Directors
• Directors

Charles H. Paul
President, C H Paul Consulting Inc

Charles H. Paul is the President of C. H. Paul Consulting, Inc. – a regulatory, training, and technical documentation consulting firm. Charles has been a regulatory consultant for over 20 years and has published numerous white papers on the subject. The firm works with both domestic and international clients designing solutions for complex training and documentation issues.

Topic Background:

GMP refers to the Good Manufacturing Practice Regulations established by the US Food and Drug Administration under the act which have the force of law. Those GMPs require that manufacturers, processors, and packagers of drugs, medical devices, some food, and blood products take proactive steps to ensure that their products are safe, pure, and effective.

Follow us :